Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Focusing of Light in the Eye01:16

Focusing of Light in the Eye

6.2K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
6.2K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unplanned Return to the Operating Room After Keratoplasty.

Cornea·2026
Same author

Six-Year outcome of ultrathin femtosecond Laser-assisted descemet stripping automated endothelial keratoplasty.

European journal of ophthalmology·2025
Same author

Corneal Complications: Drug-Induced Deposits and Food and Drug Administration Adverse Event Reporting System Data Insights-A Retrospective Study.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2025
Same author

The Protective Effect of Rho-Associated Kinase Inhibitor Eye Drops (Ripasudil) on Corneal Endothelial Cells After Cataract Surgery: A Prospective Comparative Study.

Ophthalmology and therapy·2024
Same author

Reply to Comment on: NSAIDs and corticosteroids for the postoperative management of age-related cataract surgery: a systematic review and meta-analysis.

American journal of ophthalmology·2024
Same author

Novel technique to improves graft unfolding in vitrectomized eyes during Descemet membrane endothelial keratoplasty.

International journal of surgery case reports·2024

Related Experiment Video

Updated: May 1, 2026

Comparison of Agreement and Accuracy using Binocular Wavefront Optometer with Autorefractor and Phoropter
05:14

Comparison of Agreement and Accuracy using Binocular Wavefront Optometer with Autorefractor and Phoropter

Published on: September 16, 2025

820

Refractive surgery in systemic and autoimmune disease.

Majed AlKharashi1, Kraig S Bower1, Walter J Stark1

  • 1The Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA.

Middle East African Journal of Ophthalmology
|March 27, 2014
PubMed
Summary

Laser refractive surgery (LRS) is generally not recommended for patients with systemic diseases due to potential complications. Carefully selected patients with well-controlled, mild conditions may be candidates, but more research is needed.

Keywords:
Allergic and Atopic DiseaseCollagen Vascular DiseaseDiabetes MellitusHIVKeloidLaser Refractive SurgeryPregnancy

More Related Videos

Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity
05:46

Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity

Published on: September 20, 2024

896
Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

8.4K

Related Experiment Videos

Last Updated: May 1, 2026

Comparison of Agreement and Accuracy using Binocular Wavefront Optometer with Autorefractor and Phoropter
05:14

Comparison of Agreement and Accuracy using Binocular Wavefront Optometer with Autorefractor and Phoropter

Published on: September 16, 2025

820
Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity
05:46

Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity

Published on: September 20, 2024

896
Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

8.4K

Area of Science:

  • Ophthalmology
  • Systemic Diseases
  • Refractive Surgery

Background:

  • Systemic diseases pose challenges for refractive surgery.
  • Limited literature exists on laser refractive surgery (LRS) for these patients.
  • FDA approval is lacking for LRS in this population.

Purpose of the Study:

  • To review the suitability of LRS for patients with systemic diseases.
  • To identify criteria for selecting appropriate candidates.
  • To highlight the need for further research.

Main Methods:

  • Literature review on LRS in patients with systemic conditions.
  • Analysis of contraindications and potential risks.
  • Discussion of patient selection criteria.

Main Results:

  • Patients with collagen vascular disease, diabetes mellitus (DM), allergic/atopic disease, or HIV are generally unsuitable.
  • Uncontrolled systemic disease or ocular involvement are contraindications.
  • Mild, well-controlled disease without ocular impact may allow candidacy under strict criteria.

Conclusions:

  • LRS is not currently approved for patients with systemic diseases.
  • Careful patient selection is crucial.
  • Large, multicenter trials are necessary to establish safety and efficacy.